Besides being somewhat of a buzzword in many sectors, artificial intelligence (AI) in drug development shows the potential to ...

At PMEC 2024, ACG Inspection will be launching its groundbreaking Life Sciences Cloud - a complete end-to-end analytical and ...

The pharmaceutical industry is in the midst of an incredible transformation. Advances in science and technology, changing ...

of discussion right now about the potential for artificial intelligence (AI) to transform the pharmaceutical industry (as, indeed, there is across all industries). As such, it formed the key topic ...

A tiny company in a fast-growing industry is a recipe for millionaire-making potential. And with shares up by a whopping 347% ...

SoftServe, a premier IT consulting and digital services provider, today announced the debut of its newest Generative AI (Gen AI) solution, Drug Discovery, alongside its partner NVIDIA at AWS re:Invent ...

Nvidia is spreading some of its wealth by investing in a portfolio of other artificial intelligence companies.

One company is determined to improve drug development success rates, and its cell simulation platform is already being used ...

It has been announced that global management consulting and technology firm ZS Associates has reached a definitive agreement to acquire Trials.ai, an intelligent study design company that uses ...

Diversity, equity and inclusion are not just buzzwords; they are essential principles that corporations are increasingly ...

As major corporations like Walmart turned their backs on DEI goals, other organizations have pushed artifical intelligence to ...

Bringing a drug to market from drug discovery to U.S. FDA approval can take upwards of 15 years at a cost of $2.5 billion.